These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27059685)

  • 41. Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore Access: A Multicenter Prospective Study.
    Van Mieghem NM; Latib A; van der Heyden J; van Gils L; Daemen J; Sorzano T; Ligthart J; Witberg K; de Kroon T; Maor N; Mangieri A; Montorfano M; de Jaegere PP; Colombo A; Roubin G
    JACC Cardiovasc Interv; 2017 Mar; 10(6):613-619. PubMed ID: 28335899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Collagen plug-based vascular closure devices do not decrease vascular and bleeding complications occurring after balloon aortic valvuloplasty.
    Leclercq F; Delseny D; Gervasoni R; Lattuca B; Roubille F; Cayla G; Macia JC
    Arch Cardiovasc Dis; 2015 Apr; 108(4):250-7. PubMed ID: 25754907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mynx Vascular Closure Device in Arterial Endovascular Procedures.
    Scott MC; Spencer HJ; Ali AT; Moursi MM; Escobar GA; Lyons LC; Smeds MR
    Ann Vasc Surg; 2018 Jan; 46():112-117. PubMed ID: 28546043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary Intervention.
    Marquis-Gravel G; Boivin-Proulx LA; Huang Z; Zelenkofske SL; Lincoff AM; Mehran R; Steg PG; Bode C; Alexander JH; Povsic TJ
    J Am Heart Assoc; 2023 Jan; 12(1):e025666. PubMed ID: 36583436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long term clinical outcomes after deployment of femoral vascular closure devices in coronary angiography and percutaneous coronary intervention.
    Lee SW; Ho HH; Kong SL; Lam YM; Siu CW; Miu KM; Lam L; Chan HW
    Catheter Cardiovasc Interv; 2010 Feb; 75(3):345-8. PubMed ID: 19937775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation.
    Barbanti M; Capranzano P; Ohno Y; Gulino S; Sgroi C; Immè S; Tamburino C; Cannata S; Patanè M; Di Stefano D; Todaro D; Di Simone E; Deste W; Gargiulo G; Capodanno D; Grasso C; Tamburino C
    EuroIntervention; 2015 Oct; 11(6):690-7. PubMed ID: 26499222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial.
    Sanborn TA; Tomey MI; Mehran R; Généreux P; Witzenbichler B; Brener SJ; Kirtane AJ; McAndrew TC; Kornowski R; Dudek D; Nikolsky E; Stone GW
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):371-9. PubMed ID: 25179260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simplified swift and safe vascular closure device deployment without a local arteriogram: Single center experience in 2074 consecutive patients.
    Manolis AS; Georgiopoulos G; Stalikas D; Koulouris S
    Indian Heart J; 2016; 68(4):529-38. PubMed ID: 27543479
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Arteriotomy closure device application following percutaneous coronary intervention may prevent bleeding complications in patients with acute myocardial infarction.
    Ikeno F; Sadoughi MA; Lyons JK; Raissi Shabari F; Pourdehmobed K; Hashemi V; Emami S; Kaneda H; Yeung AC; Rezaee M
    Int J Cardiol; 2007 Apr; 117(1):131-2. PubMed ID: 16935367
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of Rates of Bleeding and Vascular Complications Before, During, and After Trial Enrollment in the SAFE-PCI Trial for Women.
    Rymer JA; Kaltenbach LA; Kochar A; Hess CN; Gilchrist IC; Messenger JC; Harrington RA; Jolly SS; Jacobs AK; Abbott JD; Wojdyla DM; Krucoff MW; Rao SV
    Circ Cardiovasc Interv; 2019 May; 12(5):e007086. PubMed ID: 31014090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased bleeding risk during percutaneous coronary interventions by arterial hypertension.
    Ndrepepa G; Groha P; Lahmann AL; Lohaus R; Cassese S; Schulz-Schüpke S; Kufner S; Mayer K; Bernlochner I; Byrne RA; Fusaro M; Laugwitz KL; Schunkert H; Kastrati A
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):184-90. PubMed ID: 26526702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angioseal VIP® vs. StarClose SE® closure devices: a comparative analysis in non-cardiological procedures.
    Lucatelli P; Fanelli F; Cannavale A; Corona M; Cirelli C; D'Adamo A; Salvatori FM; Catalano C
    J Cardiovasc Surg (Torino); 2017 Feb; 58(1):80-86. PubMed ID: 24309473
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention.
    Marso SP; Amin AP; House JA; Kennedy KF; Spertus JA; Rao SV; Cohen DJ; Messenger JC; Rumsfeld JS;
    JAMA; 2010 Jun; 303(21):2156-64. PubMed ID: 20516416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Practices and complications of vascular closure devices and manual compression in patients undergoing elective transfemoral coronary procedures.
    Smilowitz NR; Kirtane AJ; Guiry M; Gray WA; Dolcimascolo P; Querijero M; Echeverry C; Kalcheva N; Flores B; Singh VP; Rabbani L; Kodali S; Collins MB; Leon MB; Moses JW; Weisz G
    Am J Cardiol; 2012 Jul; 110(2):177-82. PubMed ID: 22482861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Vascular complications at the femoral access: impact of the percutaneous closure device Perclose].
    Mboup MC; Moquet B; Zabalawi A; Delaunay R
    Ann Cardiol Angeiol (Paris); 2014 Apr; 63(2):71-4. PubMed ID: 24613004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vascular access and closure in coronary angiography and percutaneous intervention.
    Byrne RA; Cassese S; Linhardt M; Kastrati A
    Nat Rev Cardiol; 2013 Jan; 10(1):27-40. PubMed ID: 23183592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety of coronary angiography and percutaneous coronary intervention via the radial versus femoral route in patients on uninterrupted oral anticoagulation with warfarin.
    Baker NC; O'Connell EW; Htun WW; Sun H; Green SM; Skelding KA; Blankenship JC; Scott TD; Berger PB
    Am Heart J; 2014 Oct; 168(4):537-44. PubMed ID: 25262264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extravascular compared to Intravascular Femoral Closure is Associated with Less Bleeding and Similar MACE after Percutaneous Coronary Intervention.
    Kim SH; Behnes M; Baron S; Shchetynska-Marinova T; Uensal M; Mashayekhi K; Hoffmann U; Borggrefe M; Akin I
    Int J Med Sci; 2019; 16(1):43-50. PubMed ID: 30662327
    [No Abstract]   [Full Text] [Related]  

  • 59. Association between bleeding events and in-hospital mortality after percutaneous coronary intervention.
    Chhatriwalla AK; Amin AP; Kennedy KF; House JA; Cohen DJ; Rao SV; Messenger JC; Marso SP;
    JAMA; 2013 Mar; 309(10):1022-9. PubMed ID: 23483177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomised comparison of manual compression and FemoSeal™ vascular closure device for closure after femoral artery access coronary angiography: the CLOSure dEvices Used in everyday Practice (CLOSE-UP) study.
    Holm NR; Sindberg B; Schou M; Maeng M; Kaltoft A; Bøttcher M; Krusell LR; Hjort J; Thuesen L; Terkelsen CJ; Christiansen EH; Bøtker HE; Kristensen SD; Lassen JF;
    EuroIntervention; 2014 Jun; 10(2):183-90. PubMed ID: 24603054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.